GlassScriptPhysician profile
Luis Garcia
NPI 1184885162
$37,900.54
in general payments reported to CMS, 2019-2025
19 companies · $10K in 2025
The $10K reported for 2025 was more than what 81% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,420 · 2020: $1,930 · 2021: $2,713 · 2022: $8,679 · 2023: $6,595 · 2024: $4,252 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Food and Beverage: $10K · Consulting Fee: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,209.80 |
| Food and Beverage | $10,098.39 |
| Consulting Fee | $850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,895.60 | 2019-2025 | Ensite Precision, Aveir, Confirm Rx |
| Biotronik INC. | $10,670.47 | 2019-2025 | Selectra, Solia, Acticor 7 Vr-T Dx |
| Biosense Webster, INC. | $5,624.22 | 2019-2025 | Carto 3, Qdot Micro Catheter, Na |
| Medtronic, INC. | $2,698.47 | 2021-2025 | Micra, Pulseselect, Evera Mri Xt Dr Surescan |
| Medical Device Business Services, INC. | $2,156.05 | 2022-2023 | Carto 3 |
| Medtronic Vascular, INC. | $2,074.78 | 2019 | |
| Boston Scientific Corporation | $1,885.74 | 2021-2025 | General - Therapies, Farapulse, Lux-Dx Insertable Cardiac Monitor |
| Vektor Medical INC. | $639.74 | 2024-2025 | Vmap |
| Kestra Medical Technology Services, INC. | $226.24 | 2023-2024 | Assure Wcd |
| Philips North America LLC | $191.53 | 2022-2024 | (5091) Amb Mon & Diag Und |
| Impulse Dynamics (USA) INC. | $161.82 | 2025 | Optimizer |
| Cardiofocus, INC. | $144.67 | 2019 | |
| Cordis US Corp. | $132.65 | 2025 | Mynx Control Venous |
| Janssen Pharmaceuticals, INC | $101.20 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.27 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $94.88 | 2022 | |
| Zoll Respicardia, INC. | $61.99 | 2025 | Remede System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.45 | 2024-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.77 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.